New MRI scan could spare thousands from unnecessary kidney surgery
NCT ID NCT07173140
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tests whether new types of MRI scans can tell the difference between aggressive and harmless kidney tumors before surgery. Currently, standard scans can find tumors but can't tell if they are dangerous. 30 adults with small kidney tumors will get an extra MRI before their planned surgery. The goal is to see if the new MRI can accurately identify which tumors need treatment, potentially avoiding unnecessary surgery for benign ones.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
MRI scan with novel sequences
What this could lead to
If successful, this could lead to a non-invasive way to identify which kidney tumors need treatment and which can be safely monitored.
What could go wrong
This is a very small pilot study (30 people) testing a new imaging technique. It may not prove accurate enough to replace biopsies, and results may not apply to all patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RENAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University College London
London, United Kingdom